Article

Evaluating Gliclazide as a Safer Alternative Treatment for Castration- Resistant Prostate Cancer via lncRNA-Mediated Androgen Receptor Interactions

2025-07-23

Abstract excerpt

<title>Abstract</title> <p>Prostate cancer, the second most prevalent type of cancer globally, necessitates focused efforts in both diagnosis and treatment. While numerous molecules are implicated in the progression of metastatic castration-resistant prostate cancer (CRPC), the regulation of CRPC remains unknown. This study investigates this transition through bioinformatic analysis, revealing critical interactio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 182ec277-3da4-5c2c-99f5-e121aa38f4e0
DOI: 10.21203/rs.3.rs-7173327/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evaluating Gliclazide as a Safer Alternative Treatment for Castration- Resistant Prostate Cancer via lncRNA-Mediated Androgen Receptor InteractionsDOI 10.21203/rs.3.rs-7173327/v1Read

Molecular landscape for risk prediction and personalized therapeutics of castration-resistant prostate cancer: at a glanceSemantic proximity Read

Bioinformatics and system biology approaches for identifying potential therapeutic targets for prostate cancerSemantic proximity Read

The Differential Effects of Anti-Diabetic Thiazolidinedione on Prostate Cancer Progression Are Linked to the TR4 Nuclear Receptor Expression Status.Semantic proximity Read

Identification of key molecules for castration resistance prostate cancer by bioinformatic analysisSemantic proximity Read

In silico exploration of anti-prostate cancer compounds from differential expressed genesSemantic proximity Read

Identification of Androgen Receptor Variant 7-related RNAs Affecting Abiraterone Efficacy in Castration-resistant Prostate Cancer Treatment by RNA-sequencingSemantic proximity Read

The mechanistic role of long non-coding RNAs in advanced prostate cancer response to therapySemantic proximity Read

Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancerSemantic proximity Read

CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration- resistant prostate cancer by bioinformatic analysisSemantic proximity Read

Investigation of the Effects of Galectin-1 on Enzalutamide Sensitivity and Cellular Functions in Prostate Cancer Cells and Its Clinical Diagnostic ValueSemantic proximity Read

Reduced risk of prostate cancer in a cohort of Lithuanian diabetes patientsSemantic proximity Read

Clofazimine treatment modulates key non-coding RNAs associated with tumor progression and drug resistance in lethal Prostate CancerSemantic proximity Read